Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koichiro Akakura

Showing results (71-80 of 118) with videos related to

Pageof 12
Sort By:
Japanese Journal of Clinical Oncology|January 3, 2017
The efficacy and safety of docetaxel-based chemotherapy combined with dexamethasone 1 mg daily oral administration: JMTO Pca 10-01 phase II trialNobumichi Tanaka, Kazuo Nishimura, Eijiro Okajima, et al.
Journal of Radiation Research|January 4, 2017
Five-year quality of life assessment after carbon ion radiotherapy for prostate cancerKatsuya Maruyama, Hiroshi Tsuji, Takuma Nomiya, et al.
International Journal of Clinical Oncology|April 29, 2015
Prospective evaluation of the safety of transrectal ultrasound-guided transperineal prostate biopsy based on adverse eventsTakeshi Namekawa, Satoshi Fukasawa, Atsushi Komaru, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 6, 2019
Docetaxel-based chemotherapy combined with dexamethasone 1 mg daily oral administration for castration-resistant prostate cancer: Long-term outcomesNobumichi Tanaka, Kazuo Nishimura, Eijiro Okajima, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 23, 2010
Hormonal therapy for prostate cancer: current topics and future perspectivesHiroyoshi Suzuki, Shiro Hinotsu, Hideyuki Akaza, et al.
The Prostate|April 3, 2025
LHRH Antagonists Restore Serum Testosterone Faster Than LHRH Agonists in Prostate Cancer Patients After RadiotherapySangjon Pae, Shinichi Sakamoto, Xue Zhao, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 13, 2022
Carbon-ion radiotherapy for urological cancersHitoshi Ishikawa, Yuichi Hiroshima, Nobuyuki Kanematsu, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 15, 2013
Health-related quality of life after carbon-ion radiotherapy for prostate cancer: a 3-year prospective studyHiroyuki Katoh, Hiroshi Tsuji, Hitoshi Ishikawa, et al.
Cancer|March 29, 2002
Can initial prostate specific antigen determinations eliminate the need for bone scans in patients with newly diagnosed prostate carcinoma? A multicenter retrospective study in JapanShigeru Kosuda, Ichiro Yoshimura, Taku Aizawa, et al.
Cancers|August 26, 2022
Safety and Efficacy of Carbon-Ion Radiotherapy for Elderly Patients with High-Risk Prostate CancerYuichi Hiroshima, Hitoshi Ishikawa, Yuma Iwai, et al.
Pageof 12

Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
Japanese Journal of Clinical Oncology|January 3, 2017
The efficacy and safety of docetaxel-based chemotherapy combined with dexamethasone 1 mg daily oral administration: JMTO Pca 10-01 phase II trialNobumichi Tanaka, Kazuo Nishimura, Eijiro Okajima, et al.
Journal of Radiation Research|January 4, 2017
Five-year quality of life assessment after carbon ion radiotherapy for prostate cancerKatsuya Maruyama, Hiroshi Tsuji, Takuma Nomiya, et al.
International Journal of Clinical Oncology|April 29, 2015
Prospective evaluation of the safety of transrectal ultrasound-guided transperineal prostate biopsy based on adverse eventsTakeshi Namekawa, Satoshi Fukasawa, Atsushi Komaru, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 6, 2019
Docetaxel-based chemotherapy combined with dexamethasone 1 mg daily oral administration for castration-resistant prostate cancer: Long-term outcomesNobumichi Tanaka, Kazuo Nishimura, Eijiro Okajima, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 23, 2010
Hormonal therapy for prostate cancer: current topics and future perspectivesHiroyoshi Suzuki, Shiro Hinotsu, Hideyuki Akaza, et al.
The Prostate|April 3, 2025
LHRH Antagonists Restore Serum Testosterone Faster Than LHRH Agonists in Prostate Cancer Patients After RadiotherapySangjon Pae, Shinichi Sakamoto, Xue Zhao, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 13, 2022
Carbon-ion radiotherapy for urological cancersHitoshi Ishikawa, Yuichi Hiroshima, Nobuyuki Kanematsu, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 15, 2013
Health-related quality of life after carbon-ion radiotherapy for prostate cancer: a 3-year prospective studyHiroyuki Katoh, Hiroshi Tsuji, Hitoshi Ishikawa, et al.
Cancer|March 29, 2002
Can initial prostate specific antigen determinations eliminate the need for bone scans in patients with newly diagnosed prostate carcinoma? A multicenter retrospective study in JapanShigeru Kosuda, Ichiro Yoshimura, Taku Aizawa, et al.
Cancers|August 26, 2022
Safety and Efficacy of Carbon-Ion Radiotherapy for Elderly Patients with High-Risk Prostate CancerYuichi Hiroshima, Hitoshi Ishikawa, Yuma Iwai, et al.
Pageof 12